Mayinglong Pharmaceutical Group Stock Co.,Ltd.’s Net Profit Rose 3.6% in First Three Quarters of 2023

Mayinglong Pharmaceutical Group Stock Co.,Ltd. (马应龙药业集团股份有限公司) (600993.SH) reported a net profit of 430.4 million yuan in the first three quarters of 2023, up 3.6% year-on-year.

Meanwhile, the company posted 2.4 billion yuan in revenue, down 12.2% year-on-year.

At the end of the reporting period, it had 5 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 23.3%.